# Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes-----renal Substudy

> **NCT04978649** · PHASE4 · WITHDRAWN · sponsor: **Guangdong Provincial People's Hospital**

## Conditions studied

- Diabetes Mellitus, Type 2
- Blood Pressure

## Interventions

- **DRUG:** Allisartan Isoproxil
- **DRUG:** Amlodipine

## Key facts

- **NCT ID:** NCT04978649
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-09-01
- **Primary completion:** 2026-07-31
- **Final completion:** 2028-07-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Cooperation plan has been changed
- **Last updated:** 2022-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04978649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04978649, "Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes-----renal Substudy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04978649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*